AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a multicenter study recruiting patients with angioedema induced by ACEI.
Open-label treatment with subcutaneous Icatibant compared to a historic group of 47 patients
with ACE inhibitor induced angioedema which the investigators have been previously treated in
the investigators centers with current "standard" therapy (250 mg methylprednisolon and 2 mg
clemastine).
In cases with fast progression of edema after application the study-drug, a second
application with icatibant could be necessary. Rescue medication and intervention.